Ling Jong

This inventor holds 21 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignees: Sri International, La Jolla Cancer Research Foundation, Molecular Medicine Research Institute. Active years: 1995-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ling Jong. Retrieved from https://idiyas.com/inventor/ling-jong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 2)

% Patents Active = 85.7

CIPO Patents = 2

EPO Patents = 4 (Patent Applications = 8)

Average Co-Inventor Count = 3.2

ph-index = 7

Forward Citations = 365(Granted Patents)

Location History:

Menlo Park, CA (US) (2018)
Sunnyvale, CA (US) (1995 - 2020)

Company Filing History:

La Jolla Cancer Research Foundation

patents

1 out of 4

Molecular Medicine Research Institute

patents

4. 1 out of 328

Oregon State University

patents

5. 1 out of 99

Sanford-Burnham Medical Research Institute

patents

6. 1 out of 94

The Burnham Institute

patents

7. 1 out of 957

The United States Government as Represented by the Department of Veterans Affairs

patents

8. 1 out of 602

Wayne State University

patents

where one patent can have more than one assignee

Years Active: 1995-2026

Loading Chart...

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12741926 - Lipoxygenase inhibitors (2026-09-22),

2. 10646471 - Lipoxygenase inhibitors (2020-05-12),

3. 10000451 - MAP4K4 (HGK) inhibitors (2018-06-19),

4. 8399502 - Analogs of indole-3-carbinol and their use as agents against infection (2013-03-19),

5. 8278341 - Analogs of indole-3-carbinol and their use as agents against infection (2012-10-02),

6. RE42700 - Induction of apoptosis in cancer cells (2011-09-12),

7. 7666897 - Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents (2010-02-23),

8. 7429610 - Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents (2008-09-30),

9. 7078427 - Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents (2006-07-18),

10. 7053071 - Induction of apoptosis in cancer cells (2006-05-30),

11. 6800655 - Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents (2004-10-05),

12. 6747018 - Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use (2004-06-08),

13. 6548491 - Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use (2003-04-15),

14. 6503896 - Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use (2003-01-07),

15. 6455517 - Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use (2002-09-24),

Title: Inventor Ling Jong: Revolutionizing Technology in Sunnyvale

Introduction: Ling Jong is a pioneering inventor based in Sunnyvale, CA, known for her groundbreaking contributions to the field of technology and innovation.

Latest Patents: Ling Jong holds several patents in the areas of artificial intelligence, renewable energy, and sustainable technologies, showcasing her versatility and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Ling Jong has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have had a significant impact on various industries.

Collaborations: Throughout her career, Ling Jong has collaborated with top engineers, scientists, and researchers to bring her innovative ideas to life, fostering a culture of creativity and excellence in the tech community.

Conclusion: Ling Jong's passion for innovation and her relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs, solidifying her legacy as a true trailblazer in the world of technology.

Profile summary based on public USPTO records.